IRF
ICPT

IBM Retirement Fund’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

IBM Retirement Fund’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,557
Closed -$256K – 932
2016
Q3 		$256K Sell
1,557
-100
-6% -$15.8K 0.01% 884
2016
Q2 		$236K Buy
1,657
+58
+4% +$8.46K 0.01% 925
2016
Q1 		$205K Sell
1,599
-2,086
-57% -$246K 0.01% 934
2015
Q4 		$550K Buy
+3,685
New +$624K 0.01% 962
2015
Q3 		– Sell
-3,702
Closed -$894K – 1010
2015
Q2 		$894K Buy
3,702
+744
+25% +$198K 0.02% 803
2015
Q1 		$834K Hold
2,958
– – 0.02% 824
2014
Q4 		$461K Buy
2,958
+281
+10% +$51.9K 0.01% 973
2014
Q3 		$634K Sell
2,677
-335
-11% -$85.4K 0.01% 874
2014
Q2 		$717K Buy
+3,012
New +$794K 0.01% 897

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

IBM Retirement Fund's ICPT Position: Q4 2016 in Review

IBM Retirement Fund sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2016, closing a stake of 1,557 shares — an estimated $256K sold.

IBM Retirement Fund first reported a position in ICPT in Q2 2014 and held it in 9 quarters. The position peaked at $894K in Q2 2015. 159 funds tracked by Wall St. Rank hold ICPT as of Q4 2016.

  • IBM Retirement Fund reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
  • IBM Retirement Fund sold 1,557 Intercept Pharmaceuticals, Inc. shares in Q4 2016, an estimated $256K.
  • IBM Retirement Fund first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2014 and held it in 9 quarters.
  • IBM Retirement Fund's Intercept Pharmaceuticals, Inc. position peaked at $894K in Q2 2015.
  • 159 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2016.

Based on IBM Retirement Fund's 13F filing for Q4 2016, filed 10 Feb 2017.